Accession Number:

ADD018890

Title:

Application of Reversible Crosslinking and Co-Treatment in Stabilization and Viral Inactivation of Erythrocytes

Descriptive Note:

Corporate Author:

DEPARTMENT OF THE NAVY WASHINGTON DC

Report Date:

1998-02-11

Pagination or Media Count:

40.0

Abstract:

One aspect of the present invention is a method for storing tissues and cells typically erythrocytes having the step of 1 stabilizing the cells with a reversible stabilizing agent. This method typically will have the additional steps of 2 loading the cells with a cryoprotectant, and typically 3 storing the cells in liquid, frozen, or dry state. This method will also typically have the additional step of and 4 prior to use, reversing the stabilization reaction. Preferably, the erythrocytes are pre-treated with Co to complex the hemoglobin with Co. It is anticipated that a practical method according to the invention will include reoxygenation of the enthrocytes, and also washing out reagents prior to in vivo use. Another aspect of the present invention is an erythrocyte that has had its shape stabilized by the reversible crosslinking of proteins in the erythrocyte, such as the structural proteins of the cytoskeleton. Another aspect of the invention is a population of such reversibly crosslinked erythrocytes. Another aspect of the invention is the in vivo use of such erythrocytes, after the reversal of the crosslinking reaction. The use of more gentle, reversible crosslinking as described below is desirable to result in the recovery of erythrocyte deformability and extended post-transfusion survival.

Subject Categories:

  • Biochemistry
  • Organic Chemistry

Distribution Statement:

APPROVED FOR PUBLIC RELEASE